- Record: found
- Abstract: found
- Article: not found
The cost-effectiveness of ulipristal acetate tablets in treating patients with moderate to severe symptoms of uterine fibroids.
Balázs Nagy
1 ,
György Timár
2 ,
Judit Józwiak-Hagymásy
2 ,
Gábor Kovács
2 ,
Gergő Merész
2 ,
István Vámossy
3 ,
Tamás Ágh
3 ,
Ádám László
4 ,
Zoltán Vokó
1 ,
Zoltán Kaló
1
Apr 2014
There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.
Abstract
Ulipristal acetate is a selective progesterone receptor modulator that has been demonstrated to be an effective 3-month pre-operative treatment for moderate to severe symptoms of uterine fibroids in adult women of reproductive age. The aim of this analysis was to assess the cost-effectiveness of 5mg ulipristal as an add-on therapy to standard pre-surgical observation and treatment in Hungary.